| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.482 | 30.768 | 35.782 | 40.312 | 49.607 | 59.927 | 67.921 | 66.198 | 101.092 | 146.225 |
| Total Income - EUR | 29.483 | 30.768 | 35.782 | 40.313 | 49.607 | 59.968 | 67.922 | 66.199 | 101.094 | 146.227 |
| Total Expenses - EUR | 18.359 | 21.682 | 25.454 | 25.317 | 27.506 | 36.099 | 41.117 | 40.325 | 44.023 | 59.140 |
| Gross Profit/Loss - EUR | 11.124 | 9.085 | 10.329 | 14.996 | 22.101 | 23.869 | 26.804 | 25.874 | 57.071 | 87.087 |
| Net Profit/Loss - EUR | 10.239 | 8.780 | 9.971 | 14.593 | 21.605 | 23.270 | 26.125 | 25.212 | 56.060 | 82.700 |
| Employees | 5 | 0 | 4 | 0 | 3 | 3 | 3 | 3 | 0 | 3 |
Check the financial reports for the company - Polimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 606 | 122 | 0 | 0 |
| Current Assets | 21.332 | 20.092 | 21.719 | 25.648 | 32.875 | 36.470 | 28.221 | 28.269 | 59.444 | 85.548 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 21.317 | 20.092 | 21.719 | 25.648 | 32.875 | 36.470 | 28.221 | 28.269 | 59.444 | 85.548 |
| Shareholders Funds | 20.067 | 18.508 | 19.534 | 23.980 | 30.811 | 32.301 | 26.186 | 25.273 | 56.120 | 82.761 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 1.264 | 1.583 | 2.185 | 1.668 | 2.064 | 4.169 | 2.642 | 3.118 | 3.324 | 2.787 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Polimed S.r.l.